Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer.

Guerin M, Gonçalves A, Toiron Y, Baudelet E, Pophillat M, Granjeaud S, Fourquet P, Jacot W, Tarpin C, Sabatier R, Agavnian E, Finetti P, Adelaide J, Birnbaum D, Ginestier C, Charafe-Jauffret E, Viens P, Bertucci F, Borg JP, Camoin L.

Oncotarget. 2018 Sep 18;9(73):33762-33777. doi: 10.18632/oncotarget.26031. eCollection 2018 Sep 18.

2.

CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas.

Le KS, Amé-Thomas P, Tarte K, Gondois-Rey F, Granjeaud S, Orlanducci F, Foucher ED, Broussais F, Bouabdallah R, Fest T, Leroux D, Yadavilli S, Mayes PA, Xerri L, Olive D.

Blood Adv. 2018 Aug 14;2(15):1889-1900. doi: 10.1182/bloodadvances.2018017244.

3.

Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.

Le Roy A, Prébet T, Castellano R, Goubard A, Riccardi F, Fauriat C, Granjeaud S, Benyamine A, Castanier C, Orlanducci F, Ben Amara A, Pont F, Fournié JJ, Collette Y, Mege JL, Vey N, Olive D.

Front Immunol. 2018 May 4;9:977. doi: 10.3389/fimmu.2018.00977. eCollection 2018.

4.

Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010).

Olindo S, Jeannin S, Saint-Vil M, Signate A, Edimonana-Kaptue M, Joux J, Merle H, Richard P, Granjeaud S, Cabre P, Smadja D, Cesaire R, Lezin A.

PLoS Negl Trop Dis. 2018 Mar 19;12(3):e0006304. doi: 10.1371/journal.pntd.0006304. eCollection 2018 Mar.

5.

Evolutionary and expression analyses reveal a pattern of ancient duplications and functional specializations in the diversification of the Downstream of Kinase (DOK) genes.

Guittard G, Pontarotti P, Granjeaud S, Rodrigues M, Abi-Rached L, Nunès JA.

Dev Comp Immunol. 2018 Jul;84:193-198. doi: 10.1016/j.dci.2018.02.011. Epub 2018 Feb 15.

PMID:
29453999
6.

LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker.

Bressy C, Lac S, Nigri J, Leca J, Roques J, Lavaut MN, Secq V, Guillaumond F, Bui TT, Pietrasz D, Granjeaud S, Bachet JB, Ouaissi M, Iovanna J, Vasseur S, Tomasini R.

Cancer Res. 2018 Feb 15;78(4):909-921. doi: 10.1158/0008-5472.CAN-15-2790. Epub 2017 Dec 21.

7.

JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia.

De Grandis M, Bardin F, Fauriat C, Zemmour C, El-Kaoutari A, Sergé A, Granjeaud S, Pouyet L, Montersino C, Chretien AS, Mozziconacci MJ, Castellano R, Bidaut G, Boher JM, Collette Y, Mancini SJC, Vey N, Aurrand-Lions M.

Cancer Res. 2017 Dec 1;77(23):6627-6640. doi: 10.1158/0008-5472.CAN-17-1223. Epub 2017 Sep 28.

8.

NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147.

Gondois-Rey F, Chéret A, Granjeaud S, Mallet F, Bidaut G, Lécuroux C, Ploquin M, Müller-Trutwin M, Rouzioux C, Avettand-Fenoël V, Moretta A, Pialoux G, Goujard C, Meyer L, Olive D.

Clin Transl Immunology. 2017 Jul 7;6(7):e150. doi: 10.1038/cti.2017.22. eCollection 2017 Jul.

9.

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia.

Chretien AS, Fauriat C, Orlanducci F, Galseran C, Rey J, Bouvier Borg G, Gautherot E, Granjeaud S, Hamel-Broza JF, Demerle C, Ifrah N, Lacombe C, Cornillet-Lefebvre P, Delaunay J, Toubert A, Gregori E, Luche H, Malissen M, Arnoulet C, Nunes JA, Vey N, Olive D.

Front Immunol. 2017 May 29;8:573. doi: 10.3389/fimmu.2017.00573. eCollection 2017.

10.

NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.

Chretien AS, Fauriat C, Orlanducci F, Rey J, Borg GB, Gautherot E, Granjeaud S, Demerle C, Hamel JF, Cerwenka A, von Strandmann EP, Ifrah N, Lacombe C, Cornillet-Lefebvre P, Delaunay J, Toubert A, Arnoulet C, Vey N, Olive D.

Oncotarget. 2017 Jul 25;8(30):49548-49563. doi: 10.18632/oncotarget.17747.

11.

A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART.

Gondois-Rey F, Chéret A, Mallet F, Bidaut G, Granjeaud S, Lécuroux C, Ploquin M, Müller-Trutwin M, Rouzioux C, Avettand-Fenoël V, De Maria A, Pialoux G, Goujard C, Meyer L, Olive D.

Front Immunol. 2017 Feb 10;8:54. doi: 10.3389/fimmu.2017.00054. eCollection 2017.

12.

Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.

Leca J, Martinez S, Lac S, Nigri J, Secq V, Rubis M, Bressy C, Sergé A, Lavaut MN, Dusetti N, Loncle C, Roques J, Pietrasz D, Bousquet C, Garcia S, Granjeaud S, Ouaissi M, Bachet JB, Brun C, Iovanna JL, Zimmermann P, Vasseur S, Tomasini R.

J Clin Invest. 2016 Nov 1;126(11):4140-4156. doi: 10.1172/JCI87734. Epub 2016 Oct 4.

13.

Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.

Le KS, Thibult ML, Just-Landi S, Pastor S, Gondois-Rey F, Granjeaud S, Broussais F, Bouabdallah R, Colisson R, Caux C, Ménétrier-Caux C, Leroux D, Xerri L, Olive D.

Cancer Res. 2016 Aug 15;76(16):4648-60. doi: 10.1158/0008-5472.CAN-15-0589. Epub 2016 May 31.

14.

Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.

Pasero C, Gravis G, Guerin M, Granjeaud S, Thomassin-Piana J, Rocchi P, Paciencia-Gros M, Poizat F, Bentobji M, Azario-Cheillan F, Walz J, Salem N, Brunelle S, Moretta A, Olive D.

Cancer Res. 2016 Apr 15;76(8):2153-65. doi: 10.1158/0008-5472.CAN-15-1965. Epub 2016 Apr 5.

15.

Multi-parametric cytometry from a complex cellular sample: Improvements and limits of manual versus computational-based interactive analyses.

Gondois-Rey F, Granjeaud S, Rouillier P, Rioualen C, Bidaut G, Olive D.

Cytometry A. 2016 May;89(5):480-90. doi: 10.1002/cyto.a.22850. Epub 2016 Apr 5.

16.

Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia.

Chretien AS, Granjeaud S, Gondois-Rey F, Harbi S, Orlanducci F, Blaise D, Vey N, Arnoulet C, Fauriat C, Olive D.

Front Immunol. 2015 Nov 6;6:564. doi: 10.3389/fimmu.2015.00564. eCollection 2015.

17.

Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer.

Pasero C, Gravis G, Granjeaud S, Guerin M, Thomassin-Piana J, Rocchi P, Salem N, Walz J, Moretta A, Olive D.

Oncotarget. 2015 Jun 10;6(16):14360-73.

18.

Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome.

Pical-Izard C, Crocchiolo R, Granjeaud S, Kochbati E, Just-Landi S, Chabannon C, Frassati C, Picard C, Blaise D, Olive D, Fauriat C.

Biol Blood Marrow Transplant. 2015 Mar;21(3):429-39. doi: 10.1016/j.bbmt.2014.11.681. Epub 2015 Jan 9.

19.

Cerebrospinal fluid biomarker candidates associated with human WNV neuroinvasive disease.

Fraisier C, Papa A, Granjeaud S, Hintzen R, Martina B, Camoin L, Almeras L.

PLoS One. 2014 Apr 2;9(4):e93637. doi: 10.1371/journal.pone.0093637. eCollection 2014.

20.

Kinetic analysis of mouse brain proteome alterations following Chikungunya virus infection before and after appearance of clinical symptoms.

Fraisier C, Koraka P, Belghazi M, Bakli M, Granjeaud S, Pophillat M, Lim SM, Osterhaus A, Martina B, Camoin L, Almeras L.

PLoS One. 2014 Mar 11;9(3):e91397. doi: 10.1371/journal.pone.0091397. eCollection 2014.

21.

Altered protein networks and cellular pathways in severe west nile disease in mice.

Fraisier C, Camoin L, Lim SM, Bakli M, Belghazi M, Fourquet P, Granjeaud S, Osterhaus AD, Koraka P, Martina B, Almeras L.

PLoS One. 2013 Jul 10;8(7):e68318. doi: 10.1371/journal.pone.0068318. Print 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/a01d68f4-f23d-4c0a-a0f8-f32432b0efa7. Lim, Stéphanie [corrected to Lim, Stephanie M].

22.

Djeen (Database for Joomla!'s Extensible Engine): a research information management system for flexible multi-technology project administration.

Stahl O, Duvergey H, Guille A, Blondin F, Vecchio AD, Finetti P, Granjeaud S, Vigy O, Bidaut G.

BMC Res Notes. 2013 Jun 6;6:223. doi: 10.1186/1756-0500-6-223.

23.

Achieving automated scorpion venom mass fingerprinting (VMF) in the nanogram range.

Martin-Eauclaire MF, Granjeaud S, Belghazi M, Bougis PE.

Toxicon. 2013 Jul;69:211-8. doi: 10.1016/j.toxicon.2013.03.001. Epub 2013 Mar 15.

PMID:
23500507
24.

Tubulin isoforms identified in the brain by MALDI in-source decay.

Ait-Belkacem R, Calligaris D, Sellami L, Villard C, Granjeaud S, Schembri T, Berenguer C, Ouafik L, Figarella-Branger D, Chinot O, Lafitte D.

J Proteomics. 2013 Feb 21;79:172-9. doi: 10.1016/j.jprot.2012.11.026. Epub 2012 Dec 30.

PMID:
23279932
25.

Anopheles salivary gland proteomes from major malaria vectors.

Fontaine A, Fusaï T, Briolant S, Buffet S, Villard C, Baudelet E, Pophillat M, Granjeaud S, Rogier C, Almeras L.

BMC Genomics. 2012 Nov 13;13:614. doi: 10.1186/1471-2164-13-614.

26.

Multiparametric cytometry for exploration of complex cellular dynamics.

Gondois-Rey F, Granjeaud S, Kieu Sle T, Herrera D, Hirsch I, Olive D.

Cytometry A. 2012 Apr;81(4):332-42. doi: 10.1002/cyto.a.22016. Epub 2012 Jan 25.

27.

Plasmodium falciparum infection-induced changes in erythrocyte membrane proteins.

Fontaine A, Bourdon S, Belghazi M, Pophillat M, Fourquet P, Granjeaud S, Torrentino-Madamet M, Rogier C, Fusai T, Almeras L.

Parasitol Res. 2012 Feb;110(2):545-56. doi: 10.1007/s00436-011-2521-2. Epub 2011 Jul 9.

PMID:
21744020
28.

Plasmodium falciparum proteome changes in response to doxycycline treatment.

Briolant S, Almeras L, Belghazi M, Boucomont-Chapeaublanc E, Wurtz N, Fontaine A, Granjeaud S, Fusaï T, Rogier C, Pradines B.

Malar J. 2010 May 25;9:141. doi: 10.1186/1475-2875-9-141.

29.

TranscriptomeBrowser: a powerful and flexible toolbox to explore productively the transcriptional landscape of the Gene Expression Omnibus database.

Lopez F, Textoris J, Bergon A, Didier G, Remy E, Granjeaud S, Imbert J, Nguyen C, Puthier D.

PLoS One. 2008;3(12):e4001. doi: 10.1371/journal.pone.0004001. Epub 2008 Dec 23.

30.

Molecular differences between the divergent responses of ovalbumin-specific CD4 T cells to alum-precipitated ovalbumin compared to ovalbumin expressed by Salmonella.

Serre K, Mohr E, Toellner KM, Cunningham AF, Granjeaud S, Bird R, MacLennan IC.

Mol Immunol. 2008 Aug;45(13):3558-66. doi: 10.1016/j.molimm.2008.05.010. Epub 2008 Jun 25.

PMID:
18582945
31.

Entropy measures quantify global splicing disorders in cancer.

Ritchie W, Granjeaud S, Puthier D, Gautheret D.

PLoS Comput Biol. 2008 Mar 14;4(3):e1000011. doi: 10.1371/journal.pcbi.1000011.

32.

MicroArray Facility: a laboratory information management system with extended support for Nylon based technologies.

Honoré P, Granjeaud S, Tagett R, Deraco S, Beaudoing E, Rougemont J, Debono S, Hingamp P.

BMC Genomics. 2006 Sep 20;7:240.

33.

The disparate nature of "intergenic" polyadenylation sites.

Lopez F, Granjeaud S, Ara T, Ghattas B, Gautheret D.

RNA. 2006 Oct;12(10):1794-801. Epub 2006 Aug 24.

34.

Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy.

Gonçalves A, Esterni B, Bertucci F, Sauvan R, Chabannon C, Cubizolles M, Bardou VJ, Houvenaegel G, Jacquemier J, Granjeaud S, Meng XY, Fung ET, Birnbaum D, Maraninchi D, Viens P, Borg JP.

Oncogene. 2006 Feb 16;25(7):981-9.

PMID:
16186794
35.

Gene profiling reveals specific oncogenic mechanisms and signaling pathways in oncocytic and papillary thyroid carcinoma.

Baris O, Mirebeau-Prunier D, Savagner F, Rodien P, Ballester B, Loriod B, Granjeaud S, Guyetant S, Franc B, Houlgatte R, Reynier P, Malthiery Y.

Oncogene. 2005 Jun 9;24(25):4155-61.

PMID:
15806164
36.

Genomic organization and the tissue distribution of alternatively spliced isoforms of the mouse Spatial gene.

Irla M, Puthier D, Granjeaud S, Saade M, Victorero G, Mattei MG, Nguyen C.

BMC Genomics. 2004 Jul 5;5(1):41.

37.

Feature extraction and signal processing for nylon DNA microarrays.

Lopez F, Rougemont J, Loriod B, Bourgeois A, Loï L, Bertucci F, Hingamp P, Houlgatte R, Granjeaud S.

BMC Genomics. 2004 Jun 29;5(1):38.

38.

Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors.

Baris O, Savagner F, Nasser V, Loriod B, Granjeaud S, Guyetant S, Franc B, Rodien P, Rohmer V, Bertucci F, Birnbaum D, Malthièry Y, Reynier P, Houlgatte R.

J Clin Endocrinol Metab. 2004 Feb;89(2):994-1005.

PMID:
14764826
39.

Gene expression profiling of breast carcinomas using nylon DNA arrays.

Bertucci F, Loriod B, Nasser V, Granjeaud S, Tagett R, Braud AC, Patrice V, Houlgatte R, Daniel B, Nguyen C.

C R Biol. 2003 Oct-Nov;326(10-11):1031-9.

PMID:
14744110
40.

Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis.

Thieblemont C, Nasser V, Felman P, Leroy K, Gazzo S, Callet-Bauchu E, Loriod B, Granjeaud S, Gaulard P, Haioun C, Traverse-Glehen A, Baseggio L, Bertucci F, Birnbaum D, Magrangeas F, Minvielle S, Avet-Loiseau H, Salles G, Coiffier B, Berger F, Houlgatte R.

Blood. 2004 Apr 1;103(7):2727-37. Epub 2003 Nov 20.

42.
43.

Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease.

Magrangeas F, Nasser V, Avet-Loiseau H, Loriod B, Decaux O, Granjeaud S, Bertucci F, Birnbaum D, Nguyen C, Harousseau JL, Bataille R, Houlgatte R, Minvielle S.

Blood. 2003 Jun 15;101(12):4998-5006. Epub 2003 Mar 6.

44.

Prognosis of breast cancer and gene expression profiling using DNA arrays.

Bertucci F, Houlgatte R, Granjeaud S, Nasser V, Loriod B, Beaudoing E, Hingamp P, Jacquemier J, Viens P, Birnbaum D, Nguyen C.

Ann N Y Acad Sci. 2002 Dec;975:217-31.

PMID:
12538167
45.

Expression profiling in mouse fetal thymus reveals clusters of coordinately expressed genes that mark individual stages of T-cell ontogeny.

Ramialison M, Mohr E, Nal B, Saboul T, Carrier A, Tagett R, Granjeaud S, Nguyen C, Gautheret D, Jordan BR, Ferrier P.

Immunogenetics. 2002 Oct;54(7):469-78. Epub 2002 Aug 10.

PMID:
12389095
46.

Inducible antibacterial defense system in C. elegans.

Mallo GV, Kurz CL, Couillault C, Pujol N, Granjeaud S, Kohara Y, Ewbank JJ.

Curr Biol. 2002 Jul 23;12(14):1209-14.

47.

Gene expression profiling defines molecular subtypes of classical Hodgkin's disease.

Devilard E, Bertucci F, Trempat P, Bouabdallah R, Loriod B, Giaconia A, Brousset P, Granjeaud S, Nguyen C, Birnbaum D, Birg F, Houlgatte R, Xerri L.

Oncogene. 2002 May 2;21(19):3095-102.

48.

Gene expression profiles of poor-prognosis primary breast cancer correlate with survival.

Bertucci F, Nasser V, Granjeaud S, Eisinger F, Adelaïde J, Tagett R, Loriod B, Giaconia A, Benziane A, Devilard E, Jacquemier J, Viens P, Nguyen C, Birnbaum D, Houlgatte R.

Hum Mol Genet. 2002 Apr 15;11(8):863-72.

PMID:
11971868
49.

Vanin genes are clustered (human 6q22-24 and mouse 10A2B1) and encode isoforms of pantetheinase ectoenzymes.

Martin F, Malergue F, Pitari G, Philippe JM, Philips S, Chabret C, Granjeaud S, Mattei MG, Mungall AJ, Naquet P, Galland F.

Immunogenetics. 2001 May-Jun;53(4):296-306.

PMID:
11491533
50.

[Molecular typing of breast cancer: transcriptomics and DNA microarrays].

Bertucci F, Houlgatte R, Nguyen C, Benziane A, Nasser V, Granjeaud S, Tagett B, Loriod B, Giaconia A, Jacquemier J, Viens P, Birnbaum D.

Bull Cancer. 2001 Mar;88(3):277-86. Review. French.

Supplemental Content

Loading ...
Support Center